Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk (Q37421147)

20 August 2017

1 reference

title

Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk (English)

1 reference

20 August 2017

main subject

endocannabinoid system

0 references

2

Fabrizio Montecucco

1 reference

20 August 2017

François Mach

1

1 reference

20 August 2017

Sabine Steffens

series ordinal

3

1 reference

20 August 2017

publication date

1 January 2009

1 reference

20 August 2017

published in

Pharmacological Reports

1 reference

20 August 2017

volume

61

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

13-21

1 reference

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Evidence for novel cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

The endocannabinoid system: a general view and latest additions

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Endocannabinoids and the regulation of their levels in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Activation of the peripheral endocannabinoid system in human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Platelets in inflammation and atherogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Obesity, Metabolic Syndrome, and Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

The immune response in atherosclerosis: a double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

The cannabinoid system and immune modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Anandamide activates human platelets through a pathway independent of the arachidonate cascade

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Endocannabinoids and the control of energy balance

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Platelets in atherothrombosis: lessons from mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Blood pressure regulation by endocannabinoids and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

The complexities of the cardiovascular actions of cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabete

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Pharmacology: marijuana and your heart

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

The orphan receptor GPR55 is a novel cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Identification and functional characterization of brainstem cannabinoid CB2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Mesenteric vasodilation mediated by endothelial anandamide receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Platelets and chemokines in atherosclerosis: partners in crime

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970003-9

7 January 2021

10.1016/S1734-1140(09)70003-9

Identifiers

DOI

1 reference

20 August 2017

1 reference